Outset Medical to Report Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, February 21, 2024
05 Febrero 2024 - 7:30AM
Business Wire
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical
technology company pioneering a first-of-its-kind technology to
reduce the cost and complexity of dialysis, today announced that it
will release financial results for the fourth quarter and full-year
2023 after the close of trading on Wednesday, February 21,
2024.
On the same day, at 2:00 p.m. Pacific time (5:00 p.m. Eastern
time), Leslie Trigg, Chair and Chief Executive Officer, and Nabeel
Ahmed, Chief Financial Officer, will host a conference call to
discuss financial and operating results.
Conference Call Details
The conference call will begin at 2:00 p.m. Pacific time (5:00
p.m. Eastern time) on Wednesday, February 21, 2024. Those
interested in listening to the conference call may do so by
registering online. Once registered, participants will receive
dial-in numbers and a unique pin to join the call. Participants are
encouraged to register more than 15 minutes before the start of the
call. A live and archived webcast of the event will be available on
the “Investors” section of the Outset website at
https://investors.outsetmedical.com/.
About Outset Medical, Inc.
Outset is a medical technology company pioneering a
first-of-its-kind technology to reduce the cost and complexity of
dialysis. The Tablo® Hemodialysis System, FDA cleared for use from
the hospital to the home, represents a significant technological
advancement that transforms the dialysis experience for patients
and operationally simplifies it for providers. Tablo serves as a
single enterprise solution that can be utilized across the
continuum of care, allowing dialysis to be delivered anytime,
anywhere and by anyone. The integration of water purification and
on-demand dialysate production enables Tablo to serve as a dialysis
clinic on wheels, with 2-way wireless data transmission and a
proprietary data analytics platform powering a new holistic
approach to dialysis care. Tablo is a registered trademark of
Outset Medical, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240205148179/en/
Jim Mazzola Investor Relations jmazzola@outsetmedical.com
Outset Medical (NASDAQ:OM)
Gráfica de Acción Histórica
De Feb 2025 a Mar 2025
Outset Medical (NASDAQ:OM)
Gráfica de Acción Histórica
De Mar 2024 a Mar 2025